Evidence map›Paper›PMID 32705938›Full record

ArticleJournal of child neurology2020

The Neurodevelopmental and Motor Phenotype of SCA21 (ATX-TMEM240).

Emma D Burdekin, Brent L Fogel, Shafali S Jeste, Julian Martinez, Jessica E Rexach, Charlotte DiStefano, Carly Hyde, Tabitha Safari, Rujuta B Wilson

Abstract read
In one paragraph

Article in Journal of child neurology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Dystonic Tremor as Main Clinical Manifestation of SCA21.Movement disorders clinical practice · 2024
    Article
  4. Article
  5. Quantitative measures of motor development in Angelman syndrome.American journal of medical genetics. Part A · 2023
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Emma D Burdekin12222David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.ORCID 0000-0002-6049-241X
Brent L Fogel8783UCLA Department of Neurology, Program in Neurogenetics, Los Angeles, CA, USA.
Shafali S JesteSemel Institute for Neuroscience and Human Behavior, Los Angeles, CA, USA.
Julian Martinez8783UCLA Medical Genetics, Los Angeles, CA, USA.
Jessica E Rexach8783UCLA Department of Neurology, Program in Neurogenetics, Los Angeles, CA, USA.
Charlotte DiStefanoSemel Institute for Neuroscience and Human Behavior, Los Angeles, CA, USA.
Carly HydeSemel Institute for Neuroscience and Human Behavior, Los Angeles, CA, USA.
Tabitha SafariSemel Institute for Neuroscience and Human Behavior, Los Angeles, CA, USA.
Rujuta B WilsonSemel Institute for Neuroscience and Human Behavior, Los Angeles, CA, USA.

Funding

Child Neurologist Career Development Program (CNCDP)K12NS098482 · NINDS · HUGO W. MOSER RES INST KENNEDY KRIEGER · PI SCHLAGGAR, BRADLEY L · 2016 to 2025
$26.2M
UCLA Center for Translational Research in Neurodevelopment: UC-TRaNU54HD087101 · NICHD · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI MCCRACKEN, JAMES T. · 2016 to 2020
$6.5M
Quantification of Infant Motor Development to Predict Risk for Neurodevelopmental DisordersK23HD099275 · NICHD · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI WILSON, RUJUTA BHATT · 2020 to 2024
$887k
NICHD NIH HHS K23 HD099275NICHD NIH HHS U54 HD087101NINDS NIH HHS K12 NS098482
6 · The paper itself

Abstract

Spinocerebellar ataxia type 21 (SCA21/ATX-TMEM240) is a rare form of cerebellar ataxia that commonly presents with motor, cognitive, and behavioral impairments. Although these features have been identified as part of the clinical manifestations of SCA21, the neurodevelopmental disorders associated with SCA21 have not been well studied or described. Here we present extensive phenotypic data for 3 subjects from an SCA21 family in the United States. Genetic testing demonstrated the c.196 G>A (p.Gly66Arg) variant to be a second recurrent mutation associated with the disorder. Standardized developmental assessment revealed significant deficits in cognition, adaptive function, motor skills, and social communication with 2 of the subjects having diagnoses of autism spectrum disorder, which has never been described in SCA21. Quantitative gait analysis showed markedly abnormal spatiotemporal gait variables indicative of poor gait control and cerebellar as well as noncerebellar dysfunction. Clinical evaluation also highlighted a striking variability in clinical symptoms, with greater ataxia correlating with greater severity of neurodevelopmental disorder diagnoses. Notably, neurodevelopmental outcomes have improved with intervention over time. Taken together, this case series identifies that the manifestation of neurodevelopmental disorders is a key feature of SCA21 and may precede the presence of motor abnormalities. Furthermore, the coexistence of ataxia and neurodevelopmental disorders in these subjects suggests a role for spinocerebellar pathways in both outcomes. The findings in this study highlight the importance of evaluation of neurodevelopmental concerns in the context of progressive motor abnormalities and the need for timely intervention to ultimately improve quality of life for individuals with SCA21.

Indexed as

AdolescentBrainChildCognitionCommunicationFemaleGaitHumansIntellectual DisabilityMagnetic Resonance ImagingMaleMembrane ProteinsMotor SkillsMutationPhenotypeSpinocerebellar DegenerationsMembrane Proteinsataxiaautism spectrum disordergeneticsintellectual disabilityneurodevelopmental disordersSCA21spinocerebellar ataxiaTMEM240

Identifiers

PMID32705938
PMCPMC7674185

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.